Document is current
Any future updates will be listed below
-
Authors
Nakamori, Masahiro
Hosomi, Naohisa
Tachiyama, Keisuke
Kamimura, Teppei
Matsushima, Hayato
Hayashi, Yuki
Imamura, Eiji
Wakabayashi, Shinichi
Maruyama, Hirofumi
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science KAKENHI (18K10746)
- License Information
-
More Information
Article History
Received: 5 June 2020
Accepted: 4 September 2020
First Online: 2 October 2020
Competing interests
: Hirofumi Maruyama reports research support from Eisai, Pfizer, Takeda Pharmaceutical, Otsuka Pharmaceutical, Nihon Pharmaceutical, Shionogi, Teijin Pharma, Fuji Film, Boehringer Ingelheim, Sumitomo Dainippon Pharma, Nihon Medi-Physics, Bayer, MSD, Daiichi Sankyo, Kyowa Hakko Kirin, Sanofi, Novartis, Kowa Pharmaceutical, Astellas Pharma, Tsumura, Japan Blood Products Organization, Mitsubishi Tanabe Pharma, Mylan, which are unrelated to the submitted work. All other authors declare that they have no conflicts of interest.
